Medicare Enrolled

Dr. Tirso Lara, M.D.

Ophthalmology · Plantation, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
850 S. PINE ISLAND RD., Plantation, FL 33351
9547415555
Registered in NPPES since 2005
NPI: 1457353054 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lara? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lara

Dr. Tirso Lara is an ophthalmology specialist in Plantation, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Lara performed 35,824 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Lara received a total of $13,700 from 31 pharmaceutical and/or device companies across 171 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lara is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 4% volume in FL $13,700 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 93684 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
35,824
Medicare services
Top 4% in FL for ophthalmology
Not available
Unique patients (not deduplicated)
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
29,880 $29 $50
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,032 $29 $130
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
842 $89 $560
Injection, ranibizumab, 0.1 mg 802 $185 $498
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
631 $12 $100
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
493 $28 $179
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
465 $95 $340
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
395 $120 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
320 $65 $230
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
315 $214 $500
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
144 $100 $399
Aflibercept eye injection (Eylea) 142 $688 $1,250
Fluorescein angiography of retina
A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected.
95 $192 $871
Retinal and optic nerve function test
A diagnostic test that measures how well the retina and optic nerve are functioning.
95 $96 $417
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
53 $92 $465
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
53 $80 $390
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
28 $64 $270
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
24 $17 $100
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
15 $38 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,700
Total received (2018-2024)
Avg $1,957/year across 7 years
Top 12% in FL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
171
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,621
2023
$802
2022
$1,757
2021
$1,024
2020
$467
2019
$1,120
2018
$1,909

Payments by company (2024)

OnMark, Inc.
$5,656
Genentech USA, Inc.
$371
US Oncology Corporate, Inc.
$182
ABBVIE INC.
$138
Sandoz Inc.
$88
Regeneron Healthcare Solutions, Inc.
$76
Astellas Pharma US Inc
$65
ANI Pharmaceuticals, Inc.
$25
Harrow Eye, LLC
$20
Top 3 companies account for 93.8% of 2024 payments
All-time payments by company (2018-2024) ›
OnMark, Inc.
$5,656
US Retina LLC
$2,054
Genentech USA, Inc.
$1,612
Genentech, Inc.
$1,336
Regeneron Healthcare Solutions, Inc.
$1,231
ABBVIE INC.
$356
US Oncology Corporate, Inc.
$182
EyePoint Pharmaceuticals US, Inc.
$145
Coherus Biosciences Inc.
$142
Allergan Inc.
$138
Optos, Inc.
$99
Allergan, Inc.
$89
Sandoz Inc.
$88
Novartis Pharmaceuticals Corporation
$75
OPTOVUE, INC.
$66
Astellas Pharma US Inc
$65
Johnson & Johnson Surgical Vision, Inc.
$60
Bausch & Lomb, a division of Bausch Health US, LLC
$42
Alimera Sciences, Inc.
$36
ANI Pharmaceuticals, Inc.
$25
Horizon Therapeutics plc
$25
Dompe US, Inc.
$24
Merz Pharmaceuticals, LLC
$21
Sun Pharmaceutical Industries Inc.
$20
Harrow Eye, LLC
$20
Apellis Pharmaceuticals, Inc.
$20
BIOTISSUE HOLDINGS, INC.
$18
Kala Pharmaceuticals, Inc.
$18
Mallinckrodt Hospital Products Inc.
$14
Aerie Pharmaceuticals, Inc.
$13
Alcon Vision LLC
$12
Top 3 companies account for 68.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · AcrySof · BEOVU · BromSite (bromfenac ophthalmic solution) 0.075% · COMBIGAN · Cimerli · DEXYCU · ENVISTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · IHEEZO · ILUVIEN · INVELTYS · Iluvien · Izervay · LUMIGAN · Lucentis · Non-Covered Product · OCT · OXERVATE · OZURDEX · P200DTx · PROKERA · PURIFIED CORTROPHIN GEL · SUSVIMO · Susvimo · Syfovre · TEPEZZA · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · ULTRA · VABYSMO · VUITY · Vabysmo · Xeomin · YUTIQ · rhopressa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Plantation?
Compare ophthalmologists in the Plantation area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
235
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY HOSPITAL AND MEDICAL CENTER
2.3 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lara is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lara experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Lara performed 29,880 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lara receive payments from pharmaceutical companies?
Yes. Dr. Lara received a total of $13,700 from 31 companies across 171 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lara's costs compare to other ophthalmologists in Plantation?
Dr. Lara's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →